Evaluation of p53 protein expression in Barrett esophagus
نویسندگان
چکیده
منابع مشابه
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
Pathologic specimens, both biopsies and endoscopic mucosal resections, for Barrett esophagus and Barrett-associated dysplasia and malignancy are common for pathologists in North America, and the incidence in South Asian countries seems to be increasing. Dysplasia and malignancy arising in intestinalized gastric-type mucosa raises issues in the interpretation of dysplasia and the evaluation of t...
متن کاملSurveillance in Barrett Esophagus
The only known precursor of the esophageal adenocarcinoma (EAC) is represented by the Barrett's esophagus (BE). EAC incidence has increased sharply in the last 4 decades. The annual conversion rate of BE to cancer is small but significant; therefore the identification of patients at a higher risk of cancer represents a dilemma. The endoscopic surveillance of BE aims to detect dysplasia and in p...
متن کاملCommon questions about Barrett esophagus.
Barrett esophagus is a precancerous metaplasia of the esophagus that is more common in patients with chronic reflux symptoms, although it also occurs in patients without symptomatic reflux. Other risk factors include smoking, male sex, obesity, white race, hiatal hernia, and increasing age (particularly older than 50 years). Although Barrett esophagus is a risk factor for esophageal adenocarcin...
متن کاملBarrett s esophagus - a review.
Barrett’s esophagus (BE) is one of the most fascinating, challenging conditions in Gastroenterology. Its association with esophageal adenocarcinoma (ADC), explosive growth in Europe and the United States since 1980, and potential for easy diagnosis of preneoplastic lesions for follow-up and monitoring make it an appealing disease for both clinicians and researchers. The condition was named afte...
متن کاملTreatment of Dysplasia in Barrett Esophagus
Barrett esophagus is recognized as a risk factor for the development of dysplasia and adenocarcinoma of the esophagus. Cancer is usually diagnosed at an advanced stage with a 5-year survival rate of 15%. Most of these patients present de novo and are not part of a surveillance program. Endoscopic screening with improvement in recognition of early lesions may change this pattern. In the past, pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Pathology and Microbiology
سال: 2018
ISSN: 0377-4929
DOI: 10.4103/ijpm.ijpm_369_16